Terazosin
NDC 62135-460, Terazosin, capsule, from Chartwell RX, LLC.
- Product NDC
- 62135-460
- Status
- Listed
- Labeler
- Chartwell RX, LLC
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA075614
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62135-460 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TERAZOSIN HYDROCHLORIDE5 mg/1
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62135-460-90 | 62135046090 | 90 CAPSULE in 1 BOTTLE (62135-460-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/da4ca0f8-6888-447e-9948-d37196c5a19aNADAC price for package 62135046090
GET /v1/drugs/nadac/62135046090
Use it
Look up 62135-460 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62135-460 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62135-460. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.